+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Bioengineered Skin Substitutes to 2018

  • ID: 2818759
  • Report
  • May 2014
  • Greystone Associates
1 of 3
Therapeutics, Markets, Strategies and Forecasts
Damage to skin tissue from refractory wounds, surgical procedures and injury represents a growing healthcare need. Shifting demographics will drive industry growth in the years ahead as an aging population provides further stimulus for tissue repair demand. Tissue engineering is now an emerging industry with research and development taking place in the world's leading universities and companies worldwide. Emerging products and processes for wound management and tissue repair include a number of synthetic and bioengineered products that have recently become available, or are being developed, as adjuncts to wound care and/or as a replacement for human skin.


- Analyzes and evaluates the new generation of tissue-engineered and biologically active technologies and products for replacing or augmenting damaged or diseased skin

- Provides detailed analysis of bioengineered skin substitute products

- Assesses business risk factors and market issues

- Analyzes technology and product developments, and provides forecasts through 2018

- Profiles bioengineered skin substitute companies, their product development activities, and strategies
Note: Product cover images may vary from those shown
2 of 3
Executive Summary

Advanced Bioengineered Tissue Market Dynamics

Market Segmentation
Acute Wounds
Chronic Wounds & Ulcers
Surgical Wounds
Market and Patient Demographics
Market Dynamics
Factors Limiting Growth
Industry Profile
Industry Structure
Competitive Landscape
Technology Market Drivers

Bioengineered Skin Substitute Product Analysis

Acellular Matrices
Allogeneic Matrices
Allogeneic Sheets
Bilayered Skin Substitutes
Bioabsorbable Scaffolds
Extracellular Matrix
Collagen Biomembranes
Non-FDA Cleared Skin Substitutes
Extracellular Matrices
Cultured Epidermal Autografts

Market Sector Data, Assessments & Forecasts

Acute Trauma
Diabetic Ulcers
Pressure Ulcers
Venous Ulcers

Business Sector Strategies and Risks

Proprietary Technology
Near-term Capitalization
Strategic Alliances & Partnerships
Development Stage Transition Factors
Enabling Technologies

Market Factors

Clinical Trial Factors
FDA Guidelines
Evolving Patient Demographics
Point-of-Care Processing
Protocols and End-Points

Market Participant Profiles
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown